Patents/Inventors

Scott D. Schroeder

Union City, CAUS21 patents

18 Patents

US125706422026
GLP-IR Modulating Compounds
Gilead Sciences, Inc.
0 cites
US124973822025
GLP-1R Modulating Compounds
Gilead Sciences, Inc.
0 cites
US124101832025
Sars-cov2 Main Protease Inhibitors
Gilead Sciences, Inc.
0 cites
US124042622025
Therapeutic Compounds for HIV Virus Infection
Gilead Sciences, Inc.
0 cites
US122275202025
Bridged Tricyclic Carbamoylpyridone Compounds and Their Pharmaceutical Use
Gilead Sciences, Inc.
0 cites
US121801972024
GLP-1R Modulating Compounds
Gilead Sciences, Inc.
0 cites
US121102942024
CD73 Compounds
Gilead Sciences, Inc.
0 cites
US120914202024
SARS-COV2 Main Protease Inhibitors
Gilead Sciences, Inc.
0 cites
US120775372024
Capsid Inhibitors for the Treatment of HIV
Gilead Sciences, Inc.
0 cites
US120704552024
Thienopyrrole Compounds
Gilead Sciences, Inc.
0 cites
US119935832024
Therapeutic Compounds
Gilead Sciences, Inc.
0 cites
US119052992024
Cot Modulators and Methods of Use Thereof
Gilead Sciences, Inc.
0 cites
US118589182024
GLP-1R Modulating Compounds
GILEAD SCIENCES, Inc.
0 cites
US117533992023
Therapeutic Compounds
Gilead Sciences, Inc.
0 cites
US117024042023
GLP-1R Modulating Compounds
Gilead Sciences, Inc.
0 cites
US116800642023
Capsid Inhibitors for the Treatment of HIV
Gilead Sciences, Inc.
0 cites
US116614312023
Thienopyrrole Compounds
Gilead Sciences, Inc.
0 cites
US115489022023
Bridged Tricyclic Carbamoylpyridone Compounds and Their Pharmaceutical Use
Gilead Sciences, Inc.
0 cites